(PharmaNewsWire.Com, July 15, 2021 ) The major factors driving the growth of this market include the advantages of FPDs over image intensifiers, technological advancements, reimbursement cuts for analog radiography systems, and the increasing demand for minimally invasive procedures. However, the high cost of systems is estimated to restrain the growth of this market during the forecast period.
The surgical imaging market includes Tier I and II vendors GE Healthcare (UK), Siemens AG (Germany), Koninklijke Philips (Netherlands), and Ziehm Imaging (Germany) among others. The companies have a large market spread across various countries in North America, Europe, Asia Pacific, and the Rest of the World. The global COVID-19 outbreak has negatively impacted the business to a certain extent. Companies are delaying the purchase of capital expenditure due to current pandemic situation which has led to cash crunch situation for the end users of surgical imaging.
The image intensifier technology segment is expected to account for the largest share during the forecast period.
Based on technology, the surgical imaging market has been segmented into image intensifier C-arms and FPD C-arms. The image intensifier C-arms segment commanded the largest share of 75.1% of the market in 2019. However, the FPD C-arms segment is projected to register the highest CAGR during the forecast period. The large market share of this segment can be attributed to the large installed base, low price and low maintenance costs of this systems.
The orthopedic & trauma surgeries application is expected to grow at the highest rate during the forecast period.
Based on application, the market has been segmented into orthopedic & trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other applications (urological, endobronchial & thoracic, and maxillofacial surgeries). The orthopedic & trauma surgeries segment is the largest and the fastest-growing application segment in this market. This can be attributed to the increasing popularity of minimally invasive procedures in orthopedic and trauma surgeries and the advantage of 3D navigation in these surgeries through the use of C-arms.
The Hospital end user segment to account for the largest share during the forecast period
Based on end users, the market is divided into hospitals and surgery centers. Hospitals are expected to account for the largest share of the surgical imaging market in 2020, while surgery centers are expected to account for the highest growth rate. The large share of this segment can be attributed to the rising demand for effective disease management, growing surgical procedural volumes in hospitals, and the increasing number of hospitals being set up in developing countries.
North America regional segment to account for the largest market share of the surgical imaging market
Geographically, the surgical imaging market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. North America is the largest regional market for surgical imaging systems, followed by Europe. The large share of the North American market can be attributed to the significant growth in hospital expenditure, the increasing incidence of overuse sports injuries, rising prevalence of CVD, and the increasing number of hip and knee replacement surgeries in the region.
Key Players:
Some of the prominent players operating in the surgical imaging market include vendors GE Healthcare (UK), Siemens AG (Germany), Koninklijke Philips (Netherlands), and Ziehm Imaging (Germany).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
